The team’s approach rests on a protein side chain-based network method, a technique in which each amino acid residue is represented as a node, and edges are drawn between residues whose side chains come into close non-covalent contact. Such contacts include the hydrogen bonds, hydrophobic interactions, and electrostatic attractions that hold proteins together without forming chemical bonds. Rather than analyzing a single static structure, the researchers averaged their network construction over many snapshots drawn from molecular dynamics simulations produced by D. E. Shaw Research, an unusually long and detailed set of simulations that capture the complex in motion at atomic resolution. Averaging across these frames filters out fleeting, transient contacts and reveals the persistent connectivity patterns that define the complex’s functional architecture.

Once the network is built, the analysis proceeds at multiple hierarchical levels. At the most local scale, the researchers examined cliques—fully connected subgroups of residues in which every member interacts with every other member. Cliques at the viral–human interface act as tightly knit hubs of interaction, and their abundance and composition reveal how densely the two proteins interlock. At the global scale, the team analyzed clusters of connected residues and performed percolation analysis, a concept borrowed from statistical physics that asks how a network holds together as connections are progressively removed. In a percolation framework, the strongest substructures are identified by stripping away weaker links and observing which clusters survive.

The central finding of the study is unambiguous: the SARS-CoV-2 spike protein forms a more dominant and robust connection with the human ACE2 receptor than SARS-CoV-1 does. At the global level, this superiority shows up clearly in the percolation results. When the researchers restricted the networks to only the strongest interfacial bonds, the interface cluster of the SARS-CoV-2–ACE2 complex persisted, remaining a single connected unit, whereas the corresponding cluster in the SARS-CoV-1–ACE2 complex fragmented. In other words, the stronger non-covalent interactions between the newer virus and its receptor form a self-reinforcing web that cannot be dismantled by discarding weak contacts—a hallmark of structural robustness.

The atomic-scale analysis tells a complementary story. In the SARS-CoV-2 complex, network cliques at the interface form in a manner that reflects denser and better-organized inter-protein communication. Cliques are demanding structures: because every residue in a clique must contact every other, their emergence signals a level of mutual reinforcement that looser collections of contacts lack. The fact that these clique structures at the SARS-CoV-2 interface consistently encode stronger connectivity provides a mechanistic, residue-level explanation for the virus’s enhanced receptor engagement, one that emerges naturally from the geometry of interactions rather than from any single pinned atom or bond.

Beyond confirming what virologists had suspected from binding-affinity measurements, the network framework delivers something more practical: an objective method to map how atomic-level non-covalent interactions give rise to global connectivity between any two amino acids in the complex. Bridging these scales has long been a challenge in molecular biophysics. A single hydrogen bond at an interface may seem inconsequential in isolation, yet through the network it can contribute to pathways of communication that span the entire protein assembly. The side chain-network approach makes this propagation explicit, allowing researchers to trace exactly which local interactions feed into which large-scale structural couplings, and to rank residues by their contribution to overall interface integrity.

Using this ranking ability, the team pinpointed key functional residues in SARS-CoV-2 that play important roles in establishing the higher connectivity with ACE2. These residues, identified through their network centrality and their participation in robust interfacial clusters and cliques, constitute the structural backbone of the viral grip on human cells. The authors also examined specific individual snapshots from the molecular dynamics trajectories rather than only time-averaged networks, and this analysis highlighted prominent variations in network topology across different conformations. The spike–ACE2 complex does not sit in a single rigid state; it explores a diverse conformational landscape, and the connectivity architecture shifts meaningfully from one moment to another. Capturing these fluctuations matters because a receptor-binding interface is a dynamic entity, and transient configurations may expose vulnerabilities or reveal alternative interaction modes.

Perhaps the most striking connection to real-world virology emerges when the network map is overlaid with the evolutionary record of the pandemic. The researchers found that most mutations occurring in the SARS-CoV-2 spike protein in variants of concern and variants of interest—including the currently active JN.1 variant and its subvariants—have been observed at the interface with the ACE2 receptor. This is precisely the region that the network analysis identifies as the seat of the virus’s enhanced connectivity. The convergence is telling: as the virus evolves to evade immunity generated by prior infection or vaccination, natural selection keeps returning to the same interfacial neighborhood that network science flags as functionally dominant. Mutations there can simultaneously alter antibody recognition and tune receptor binding, which explains why this region is both the engine of immune escape and the object of intense surveillance by public health laboratories worldwide.

This convergence between evolutionary observation and network topology gives the study practical significance for therapeutic design. If a defined set of residues sustains the robust connectivity between the viral spike and ACE2, then molecules that mimic the relevant receptor surface could, in principle, compete with ACE2 for spike binding and neutralize the virus. The authors note that their analyses highlight the importance of interface interactions and provide a rationale for designing receptor-like peptides and proteins to combat immunity-escaping variants. Because such decoys target the physical grip on ACE2 rather than the antibody-recognized epitopes that mutate most rapidly under immune pressure, they may retain effectiveness even as the virus drifts genetically—a property that conventional antibody drugs increasingly struggle to maintain against JN.1-descended lineages.

More broadly, the work demonstrates the value of complex-systems thinking in molecular biology. A virus–receptor complex is not merely a collection of atoms or a static ribbon diagram; it is a network whose resilience, communication pathways, and failure points determine biological function. By providing an objective, quantitative bridge from atomic non-covalent interactions to global connectivity between any two amino acids, the framework developed by Subramanyan and colleagues can in principle be applied to any protein complex, well beyond coronaviruses. For SARS-CoV-2 specifically, it delivers a durable conceptual map of why this virus binds human cells so effectively, why evolution keeps redrawing the same interfacial territory, and where next-generation antiviral designs might most productively aim as the virus continues to diversify.

Subject of Research: Network analysis of the SARS-CoV-2 spike–human ACE2 receptor complex connectivity

Article Title: From atomic to global connectivity in the structure of the SARS-CoV2-human ACE2 receptor complex

Article References: Subramanyan, V., Anto, A., Bhattacharyya, M., Vishveshwara, S., & Vishveshwara, S. (2026). From atomic to global connectivity in the structure of the SARS-CoV2-human ACE2 receptor complex. PLOS Complex Systems, 3(4), e0000096. https://doi.org/10.1371/journal.pcsy.0000096

Image Credits: AI Generated

DOI: 10.1371/journal.pcsy.0000096

Keywords: SARS-CoV-2, ACE2 receptor, spike protein, SARS-CoV-1, molecular dynamics, protein structure networks, percolation analysis, network cliques, variants of concern, JN.1 variant, immune escape, peptide design